Pfizer vaccine

Los Angeles: The US Centers for Disease Control and Prevention (CDC) and the US Food and Drug Administration (FDA) have announced that their surveillance system flagged a possible link between the new Pfizer-BioNTech bivalent Covid-19…
Read More...

New York: Covid-19 infections in the 'fully' vaccinated are rare but are more common and severe in people with weaker immune systems, according to a real-world retrospective study led by the US drug maker Pfizer involving nearly 1.2 million…
Read More...

New York: Two doses of Pfizer-BioNTech (BNT162b2) are 90 per cent effective against Covid-19 hospitalisations for all variants, including delta, for at least six months, confirms a new study published in The Lancet However, effectiveness…
Read More...

London: Two doses of the Pfizer coronavirus vaccine can potentially protect children from thousands of cases of long Covid, suggests a new study. The US Food and Drug Administration (FDA) has approved two doses of Pfizer-BioNTech…
Read More...

London: The UK's health regulator has approved Pfizer and AstraZeneca vaccines for booster doses against Covid-19, even as the country's decision on the third dose remains pending. "We know that a person's immunity may decline over time…
Read More...

New Delhi: The Union Health Ministry categorised the Delta Plus variant of the novel coronavirus as a ‘variant of concern’. Delta variant has mutated into Delta Plus which is said to be highly infectious. According to sources, India…
Read More...

New York: An arthritis drug -- Tofacitinib -- developed by US biopharmaceutical Pfizer has shown to be effective in reducing the risk of death or respiratory failure in hospitalised adult patients with Covid-19 pneumonia who were not on…
Read More...

London: Two doses of Pfizer and AstraZeneca's Covid-19 vaccines are highly effective against hospitalisation from the Delta (B16172) variant, according to new analysis from Public Health England (PHE). The analysis suggests that the…
Read More...

New York: The two-dose regimen of Pfizer-BioNTech vaccines reduced asymptomatic infection, finds a study. The study, led by St. Jude Children's Research Hospital showed that vaccination reduced the risk of asymptomatic infections by 72 per…
Read More...

Canberra: Australia's Covid-19 vaccination rollout will begin next Monday as the first 142,000 doses of the Pfizer/BioNTech vaccine landed in the country, Health Minister Greg Hunt said. Hunt said the vaccines landed in Sydney just after…
Read More...